Patient Recruitment White Paper & Articles
-
How To Accelerate Early-Phase Oncology Trial
5/12/2026
Purpose-built early-phase oncology sites can enroll patients within 7–10 days post-activation while maintaining quality and diversity; academic centers often lag due to complexity and saturation.
-
Ways To Avoid Rescue Trials From The Start
5/12/2026
What puts a trial in rescue mode? Poor clinical planning, overly complex protocols, missed deadlines, insufficient resources, and noncompliance are a few reasons. Sponsors can avoid a rescue in the first place by addressing these obstacles before they become delays.
-
How To Improve Patient Engagement In Clinical Trials
4/21/2026
Stronger patient engagement improves recruitment, retention, and data quality. Reducing burden, improving communication, and meeting real needs can transform trials and keep studies on track.
-
Where Study Simulation Fits In Clinical Trials
4/21/2026
Simulation lets teams test assumptions early, showing how design and operations affect timelines, cost, and feasibility — reducing risk and enabling confident, data‑driven decisions.
-
A Guide To Patient Engagement And Recruitment Solutions
4/16/2026
In this text we explore strategic solutions to patient recruitment and engagement challenges, emphasizing the importance of comprehensive patient engagement and recruitment strategies.
-
Ophthalmology Patient Engagement And Retention: Point-Of-Need Execution
4/6/2026
Dropout in retinal trials is often a logistical failure. Reducing travel burden and bringing specialized care to the patient can slash attrition rates and secure critical trial timelines.
-
Mastering Precision Oncology Start-Up: Reducing Screening Delays
3/30/2026
Biomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.
-
How To Reduce Eligibility Risk And Prevent Protocol Deviations
3/18/2026
Eliminate enrollment-based protocol deviations and align with the latest FDA guidance by implementing a centralized, technology-enabled eligibility review to safeguard trial integrity.
-
Why Are Sponsors Prioritizing Ophthalmology Clinical Trials?
3/18/2026
Explore how demographic shifts and retinal innovation are transforming ophthalmology trials, and why operational precision is the key to protecting data integrity in this high-growth sector.
-
Best Practices In Rare Disease Patient Recruitment
3/9/2026
Recruiting for rare disease clinical trials is daunting, and making patients aware of clinical trials, involving them in trial design, and building trust are a few ways sponsors can boost recruitment.